<DOC>
	<DOCNO>NCT01291381</DOCNO>
	<brief_summary>While allergen specific immunotherapy ( SIT ) highly effective allergic diseases child , underlie immunological mechanism unclear . Regulatory T ( Treg ) cell may crucial induction tolerance . Our aim investigate role CD4+CD25+Foxp3+ T cell IL-10-secreting type I T regulatory ( Tr1 ) cell response one year cluster SIT Dermatophagoides pteronyssinus allergic rhinitis child . CD4+CD25+Foxp3+regulatory T cell IL-10-secreting type I T regulatory ( Tr1 ) cell analyzed child allergic Dermatophagoides pteronyssinus one year cluster specific immunotherapy ( SIT ) prospective randomize study . Peripheral blood mononuclear cell ( PBMCs ) collect 25 child receive SIT 21 receive pharmacotherapy . The frequency CD4+CD25+Foxp3+ T cell allergen-specific IL-10+IL-4- , IFN-γ+IL-4- , IL-4+IFN-γ-CD4+ T cell measure flow cytometry . Production IL-4 , IFN-r , IL-10 supernatants allergen-stimulated PBMC culture measure ELISA . Finally , suppressive effect CD4+CD25highTreg cell group estimate .</brief_summary>
	<brief_title>Distinct Response CD4+CD25+Foxp3+ IL-10-secreting Type I T Regulatory Cells Cluster Specific Immunotherapy Allergic Rhinitis Children</brief_title>
	<detailed_description>Patients The design one-year , randomized open-label parallel group study patient randomize 1:1 ratio receive SIT Dermatophagoides pteronyssinus extract ( Alutard SQ , ALK-Abello ' , Hørsholm , Denmark ) observe standard pharmacotherapy ( control group ) . The study participant include 50 house dust mite ( HDM ) -allergic child age 9-13 , receive SIT Dermatophagoides pteronyssinus ( Der p ) extract one year . These compare 21 HDM-allergic child age 9-14 served control . All child Han nationality recruit allergy clinic Beijing TongRen Hospital . They history HDM-induced moderate severe rhino-conjunctivitis least three year duration . Each patient also positive skin prick test ( SPT ) result Der p ( ALK-Abello ' , Hørsholm , Denmark ) wheal diameter least 6 mm , positive specific immunoglobulin E ( IgE ) Der p ( Pharmacia CAP System , Pharmacia Diagnostics , Uppsala , Sweden ) , RAST value least 0.7 kU/L . Children history asthma atopic dermatitis exclude . The child undergo immunotherapy match atopic donor age , sex , SPT response Der p , total IgE specific IgE Der p level ( Table 1 ) . The study protocol approve institutional review board human study inform consent obtain subject . Immunotherapy protocol Children undergo subcutaneous immunotherapy give Dermatophagoides pteronyssinus extract ( Alutard SQ , ALK-Abello , Hørsholm , Denmark ) accord cluster protocol describe previously [ 15 ] . In first six week , child underwent visit up-dosing , receive two injection one hour apart increase dose every week . The high concentration , give sixth week , allergenic activity 100,000 SQ/ml contain 9.8 μg/ml Der p1 . After week six , dose interval increase one month maintain end first year . For patient randomized non-SIT group , persistent rhinitis manage pharmacotherapy include intranasal steroid oral antihistamine . Intranasal steroids keep dose study antihistamine use require . Blood sample take baseline one year treatment group . Clinical evaluation Symptoms AR child assess Total 5 Symptom Score ( T5SS ) , include rhinorrhea , sneeze , nasal congestion , nasal ocular pruritus . Each symptom score scale 0-3 ( 0 = none , 3 = severe ) . Medication use score recorded daily , describe previously [ 16 ] . Arbitrary score attribute drug use ( 0.75 point 1 puff nasal corticosteroid 1 point 1 tablet antihistamine ) . Patients instruct use local steroid ( plus antihistamine improve symptom ) report administration variation initial drug therapy diary . Patients also instruct stop drug least 7 day blood sampling . Flow cytometry Peripheral blood obtain venous puncture collect preservative-free heparin . Peripheral blood mononuclear cell ( PBMCs ) isolate mean Ficoll-Plaque Plus density gradient centrifugation ( Amersham Biosciences , NJ , USA ) . For intracellular detection cytokine , PBMCs ( 2 × 106 cells/mL ) stimulate 10 μg/mL Der p1 ( D. pteronyssinus major allergen 1 , Indoor Biotechnologies , United Kingdom ) 24 hour . Twenty-five ng/mL phorbol 12-myristate 13-acetate ( PMA ) , 1 μg/mL ionomycin 1.7 μg/mL monensine add 37 °C final four hour stimulation ( Sigma , Missouri , USA ) . For flow cytometry , PBMCs surface stain room temperature 20 minute anti-CD4-PerCP anti-CD25-PE , isotype control ( mouse IgG1-PerCP IgG1-PE ) ( Beckman Coulter , CA , USA ) . For intracellular staining Foxp3 , cell fix permeabilized Foxp3 fixation/permeabilization buffer , stain anti-human Foxp3-FITC isotype control ( IgG1-FITC ) ( BioLegend , CA , USA ) . For intracellular cytokine analysis , Der p1-stimulated PBMCs surface stain anti-CD3-APC anti-CD8-PerCP , fixed 4 % paraformaldehyde/PBS . After permeabilized use FACS Permeabilizing Solution ( BD Pharmingen , CA , USA ) , cell incubate 30 minute room temperature anti-IL-4-PE plus anti-IFN-γ-FITC , anti-IL-10-PE plus anti-IL-4-FITC , antibody match respective isotype IgG1 control ( BD Pharmingen ) . Different T subset select detailed phenotypic analysis follow : ( 1 ) Th1 cell : IFN-γ+IL-4-CD3+CD8- T cell ; ( 2 ) Th2 cell : IL-4+IFN-γ-CD3+CD8- T cell ; ( 3 ) Tr1 cell : IL-10+IL-4-CD3+CD8- T cell . For analysis , least 20,000 event collect . Analysis conduct use FACSCalibur flow cytometer ( BD Biosciences , NJ , USA ) . ELISA PBMCs resuspend 2 × 106 cells/mL RPMI-1640 medium stimulate 10 μg/mL Der p1 ( D. pteronyssinus major allergen 1 , Indoor Biotechnologies , United Kingdom ) . Cultures incubate 6 day 37 ºC humidify incubator contain 5 % CO2 . Supernatants allergen-stimulated PBMCs culture assay presence IFN-γ , IL-4 , IL-10 mean ELISA ( R &amp; D Systems , Minneapolis , USA ) . Isolation CD4+CD25high Treg cell Heparinized blood obtain eight recruit SIT-treated child eight AR control cell isolation functional analysis . After non-CD4+ cell PBMCs remove LD column biotin-antibody cocktail antibiotin microbeads , CD4+ T cell isolate PBMCs negative selection , CD4+CD25+ T cell positively select CD4+ T cell . Finally , CD25- fraction recover use MS-magnetic column use human CD4+CD25+ regulatory T cell isolation kit accord manufacturer 's instruction ( Miltenyi Biotec , Germany ) . Cells high CD25 expression ( CD25high ) select incubation limit quantity anti-CD25 antibody bead ( 2 μl anti-CD25 beads/107 cell ) [ 17 ] . The mean purity isolate CD4+ 95 % ( 93-97 % ) 76 % ( 72-88 % ) CD4+CD25high T cell Foxp3-positive . Suppressive capacity CD4+CD25high Treg cell To evaluate suppressive capacity CD4+CD25high Treg cell , cell proliferation cytokine analyze . CD4+CD25- T cell ( responder ) alone mixed CD4+CD25- T cell CD4+CD25high T cell ( suppressor ) ratio 2:1 cultured final volume 200 µl RPMI-1640 medium 10 µg/ml Der p1 . Cultures incubate 6 day 37 ºC humidify incubator 5 % CO2 . Autologous irradiate PBMCs ( 3000 rad ) add 2 × 105 antigen-presenting cell CD4+CD25- T cell culture . In case , triplicate medium well include negative control . At day six , 100 µl supernatant remove Th1 Th2 cytokine ( IFN-γ IL-4 ) analysis ELISA kit ( R &amp; D Systems , Minneapolis , USA ) . Cell proliferation CD4+CD25- T cell assess use WST-8 ( modify tetrazolium salt ) cell proliferation kit ( Cell Counting Kit-8 , Dojin , Japan ) accord manufacturer ' protocol . The proliferation result express absorbance 450nm culture medium . Statistics Statistical significance group analyze use Mann-Whitney test . The significance intra-group pre- post-therapy change determine use nonparametric Wilcoxon match pairs test . The correlation coefficient r generate use Pearson correlation . All analysis perform use SPSS version 13.0 statistical software . A 5 % significance level use ( α = 0.05 ) , power ( 1- β ) equal 90 % . All test 2-tailed , P value less 0.05 consider statistically significant .</detailed_description>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Histamine Antagonists</mesh_term>
	<mesh_term>Histamine H1 Antagonists</mesh_term>
	<criteria>Clinical diagnosis Allergic rhinitis Han nationality Had history HDMinduced moderate severe rhinoconjunctivitis least three year duration Had positive skin prick test ( SPT ) result Der p ( ALKAbello ' , Hørsholm , Denmark ) wheal diameter least 6 mm Were positive specific immunoglobulin E ( IgE ) Der p ( Pharmacia CAP System , Pharmacia Diagnostics , Uppsala , Sweden ) , RAST value least 0.7 kU/L Clinical diagnosis asthma</criteria>
	<gender>All</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>allergic rhinitis</keyword>
	<keyword>peripheral tolerance</keyword>
	<keyword>regulatory T cell</keyword>
	<keyword>specific immunotherapy</keyword>
	<keyword>Tr1 cell</keyword>
</DOC>